Medicinal Plants of the World, 2nd Edition, Vol 1 Edited by Ivan A. Ross (U.S. Food and Drug Administration). Humana Press, Totowa, NJ. 2003. xv + 491 pp. 7 × 11 in. $99.50. ISBN 1-58829-281-9.

2004 ◽  
Vol 67 (10) ◽  
pp. 1771-1772
Author(s):  
Ehab A. Abourashed
2020 ◽  
Vol 9 (8) ◽  
pp. 320-324
Author(s):  
Kate Kelso

Regulations to which dermal filler manufacturers must adhere so as to bring a product to market vary across the world. It is recognised that standards of the EU Medical Device Directive were inadequate, and, as a result of this, it is due to be replaced by the EU Medical Device Regulation (MDR) ( EU 2017 /745) on 26 May 2021. The EU CE mark will continue to be recognised in the UK until 30 June 2023. Typically, the more rigorous US Food and Drug Administration (FDA) process has been more trusted, but will this still be the case when the MDR comes into force? This piece contrasts and compares the new EU MDR and FDA regulation from an injector perspective.


1988 ◽  
Vol 51 (8) ◽  
pp. 655-657 ◽  
Author(s):  
STEPHEN D. WEAGANT ◽  
PATRICIA N. SADO ◽  
KAREN G. COLBURN ◽  
JAMES D. TORKELSON ◽  
FRED A. STANLEY ◽  
...  

Samples of frozen seafood products from several countries were tested for the presence of Listeria monocytogenes and other Listeria species using the U.S. Food and Drug Administration (FDA) Listeria isolation method. Of 57 samples tested, 35 contained Listeria species and 15 of 57 samples contained L. monocytogenes. Samples found positive included raw shrimp, cooked and peeled shrimp, cooked crabmeat, raw lobster tails, langostinos, scallops, squid and surimi-based imitation seafoods. Positive samples were obtained from nine different countries around the world.


2001 ◽  
Vol 2 (4) ◽  
pp. 261-266
Author(s):  
S. Martina ◽  
C. Denti ◽  
E. Daina ◽  
L. Garattini

Aim of this study is to check the Italian market of the orphan drugs in connection with rare diseases. Data for the research have been found on the Food and Drug Administration Database, the Centro di Ricerche Cliniche per le Malattie Rare “Aldo e Cele Daccò” Database and L’informatore farmaceutico. This study also compared the Italian market with the American market, that counts the greater number of designated orphan drugs and commercial authorizations in the world. In Italy only 24 orphan drugs have been authorized by the Ministry of Health and the present work analyzes their definition under the economic profile, how many diseases and what kind of pathologies they can treat, the number of products on the market and if they are refundable or not.


Sign in / Sign up

Export Citation Format

Share Document